💨 Abstract

Celldex Therapeutics reported a second-quarter loss of $56.6 million, or 85 cents per share, exceeding Wall Street's expected loss of 86 cents per share. However, the company's revenue of $730,000 fell short of analyst forecasts of $1.7 million.

Courtesy: WTOP Staff